Form 4: Myriad Genetics Executive Kevin Richard Haas Reports Stock Transaction
SEC Form 4 Filing
Chief Technology Officer Kevin Richard Haas of Myriad Genetics Inc. reports disposition of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On October 9, 2024, Kevin Richard Haas, Chief Technology Officer of Myriad Genetics Inc., reported a transaction involving the company's common stock.
- Haas disposed of 2,515 shares to satisfy tax withholding obligations related to the vesting of restricted stock units.
- The shares were disposed of at a price of $24.37 per share.
- Following the transaction, Haas directly owns 129,582 shares of Myriad Genetics Inc.
Sentiment
Score: 5
Explanation: This is a routine filing related to tax obligations, so it doesn't significantly impact sentiment. It's a neutral event.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be an indicator of management's perspective on the company's valuation and future prospects.
Key Dates
| Date | Description |
|---|---|
| 10/09/2024 | Date of stock transaction (disposal of shares). |
| 10/10/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.